Fortinet Wins Google Cloud Technology Partner of the Year Award for Security – Identity & Endpoint Protection
SUNNYVALE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Kevin Ichhpurani, Corporate Vice President, Global Ecosystem…
SUNNYVALE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Kevin Ichhpurani, Corporate Vice President, Global Ecosystem…
Calgary, Alberta–(Newsfile Corp. – August 29, 2023) – ICEsoft Technologies Canada Corp. (CSE: ISFT) (the…
Calgary, Alberta–(Newsfile Corp. – August 29, 2023) – ICEsoft Technologies Canada Corp. (CSE: ISFT) (the…
Global Spirits USA is operating as a normal online store and celebrating Ukrainian Independence Day…
New York, New York–(Newsfile Corp. – August 29, 2023) – HOPE Hydration and Wollman Park…
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology,…
HONG KONG, Aug 29, 2023 – (ACN Newswire) – Everbright Grand China Assets Limited (“Everbright…
HONG KONG, Aug 29, 2023 – (ACN Newswire) – Dynasty Fine Wines Group Limited (“Dynasty”…
MONTREAL, QUEBEC, Aug 29, 2023 – (ACN Newswire) – Today, Flojoy announces an oversubscribed seed…
HONG KONG, Aug 29, 2023 – (ACN Newswire) – Baguio Green Group Limited (“Baguio” or…
MasterMechanic is the ‘ChatGPT for HVAC techs’ — providing them actionable, real-world answers to very…
Velayutham has over a decade of product and technology experience, with accomplishments that include building…
Specialized lab expands SoftServe’s AI/ML capabilities to accelerate Generative AI value discovery and real-world adoption…
Synthetaic will take advantage of Microsoft’s investment of significant cloud GPU compute access to fuel…
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC…
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC…
– $5.5 million first six-month 2023 sales vs. $11.7 million for the same period in…
– $5.5 million first six-month 2023 sales vs. $11.7 million for the same period in…
Celularity to provide research support for Regeneron’s targeted, allogeneic, chimeric antigen receptor (CAR) T-cell therapy…
Celularity to provide research support for Regeneron’s targeted, allogeneic, chimeric antigen receptor (CAR) T-cell therapy…